Naturally fluctuating low incidence of invasive pneumococcal infections not affected by large-scale haemophilus influenzae type B vaccination

Pediatric Infectious Disease Journal

Volumn 29, Issue 8, 2010, Pages 777-779

  Peltola, Heikki ^a   Helminen, Merja ^b   Vuento, Risto ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

epidemiology; Haemophilus influenzae; incidence; pneumococcus; Streptococcus pneumoniae; vaccination

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HAEMOPHILUS VACCINE;

ADOLESCENT; ARTICLE; BLOOD ANALYSIS; CEREBROSPINAL FLUID CULTURE; CHILD; FOLLOW UP; HAEMOPHILUS INFECTION; HUMAN; INCIDENCE; NEWBORN; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STREPTOCOCCUS INFECTION; BACTEREMIA; BLOOD; CEREBROSPINAL FLUID; FINLAND; HAEMOPHILUS INFLUENZAE TYPE B; IMMUNIZATION; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; PNEUMOCOCCAL INFECTIONS; PROSPECTIVE STUDY; STREPTOCOCCUS PNEUMONIAE; UTILIZATION;

ADOLESCENT; BACTEREMIA; BLOOD; CEREBROSPINAL FLUID; CHILD; CHILD, PRESCHOOL; FINLAND; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION; INCIDENCE; INFANT; INFANT, NEWBORN; PNEUMOCOCCAL INFECTIONS; PROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE;

EID: 77955175703     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181dbd820     Document Type: Article

References (27)

1. Nikoskelainen J, Lähtönen E, Leino A, et al. Is group-specific meningococcal vaccination resulting in epidemics caused by other groups of virulent meningococci? Lancet. 1978;312:403-405.
2. Takala A, Eskola J, Leinonen M, et al. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis. 1991;164:982-986.
3. Waggoner-Fountain LA, Hendley JO, Cody EJ, et al. The emergence of Haemophilus influenzae types e and f as significant pathogens. Clin Infect Dis. 1995;21:1322-1324.
4. Urwin G, Krohn JA, Deaver-Robinson K, et al, the Haemophilus influenzae Study Group. Invasive disease due to Haemophilus influenzae serotype f: clinical and epidemiological characteristics in the H. influenzae serotype b vaccine era. Clin Infect Dis. 1996;22:1069-1076.
5. Campos J, Romàn F, Pérez-Vazquez M, et al. Infection due to Haemophilus influenzae serotype: microbiological, clinical, and epidemiological features. Clin Infect Dis. 2003;37:841-845.
6. Foster JA, McGowan KL. Rising rate of pneumococcal bacteremia at the Children's Hospital of Philadelphia. Pediatr Infect Dis J. 1994;13:1143-1144.
7. Baer M, Vuento R, Vesikari T. Increase in bacteraemic pneumococcal infections in children. Lancet. 1995;345:661.
8. Ward JI. Editorial response: invasive infections due to Haemophilus influenzae serotype f (Hif)-is Hif an emerging pathogen? Clin Infect Dis. 1996;22:1077-1078.
9. Kilpi T, Åhman H, Jokinen J, et al. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex vaccine in 1666 children. Clin Infect Dis. 2003;37:1155-1164.
10. Pelton SI. Replacement pneumococcal disease in perspective. Clin Infect Dis. 2008;46:1353-1355.
11. Calbo E, Diaz A, Canadell E, et al. Invasive pneumococcal disease among children in a health district of Barcelona; early impact of pneumococcal conjugate vaccine. Clin Microbiol Infect. 2006;12:867-872.
12. Obando I, Arroyo LA, Sánchez-Tatay D, et al. Molecular epidemiology of paediatric invasive pneumococcal disease in southern Spain after the introduction of heptavalent pneumococcal conjugate vaccine. Clin Microbiol Infect. 2006;13:347-348.
13. Messina AF, Katz-Gaynor K, Barton T, et al. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Pediatr Infect Dis J. 2007;26:461-467.
14. Muñoz-Almagro C, Jordan I, Gene A, et al. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis. 2008;6:174-182.
15. Bender JM, Ampofo K, Daly J, et al. Pneumococcal necrotizing pneumonia in Utah: does serotype matter? Clin Infect Dis. 2008;46:1346-1352.
16. Lepoutre A, Varon E, Georges S, et al. Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006. Euro Surveill. 2008;28:13(35).
17. Booy R, Heath P, Willocks L, et al. Invasive pneumococcal infections in children. Lancet. 1995;345:1245-1246.
18. Klemets P, Lyytikäinen O, Ruutu P, et al. Trends and geographical variation in invasive pneumococcal infections in Finland. Scand J Infect Dis. 2008; 40:621-628.
19. Peltola H, Salo E, Saxén H. Incidence of Haemophilus influenzae type b meningitis during 18 years of vaccine use: observational study using routine hospital data. BMJ. 2005;330:18-19.
20. Koskikallio E, Salo E, Kaijalainen T, et al. Clinical severity of invasive pneumococcal infections of children. An analysis of 85 cases in Finland. J Finn Med Ass. 2004;59:1893-1898-In Finnish, abstract in English.
21. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737-1746.
22. Ardanuy C, Tubau F, Pallares R, et al. Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007. Clin Infect Dis. 2009;48:57-64.
23. Jefferson T, Ferroni E, Curtale F, et al. Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old. Lancet Infect Dis. 2006;6:405-410.
24. Vestereim DF, Løvoll Ø, Aaberge IS, et al. Effectiveness of a 2-1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal diseases among children in Norway. Vaccine. 2008;26: 3277-3281.
25. Casado-Flores J, Rodrigo C, Arístegui J, et al. Decline in pneumococcal meningitis in Spain after introduction of the heptavalent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2008;27:1020-1021.
26. Schuerman L, Borys D, Hoet B, et al. Prevention of otitis media: now a reality? Vaccine. 2009;27:5748-5754.
27. Veenhoven R, Bogaert D, Uiterwaal C, et al. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent otitis media: a randomised study. Lancet. 2003;361: 2189-2195.